S0414 - MHRA Townhall

Thu, Mar 20, 2025 · 8:30–9:40 AM CET San Francisco Room, Congress Center Basel

About this session

This session will provide an overview of latest activities and initiatives at MHRA. The session will cover new approaches to support innovation and streamline and enhance clinical trials in the UK, our initiatives to promote and accelerate access to new medical products, approaches to enhance and improve evidence generation including the launch of our RWE scientific dialogue programme and ways in which we are addressing the technological and data opportunities

Programme:
- Panel Discussion — Claire Harrison, James Pound, Jon Beaman

Speakers

James Pound

Interim Executive Director for Innovation and Compliance · Medicines and Healthcare Products Regulatory Agency (MHRA)

Panelist
Jon Beaman

Deputy Director for Innovative Medicines (Healthcare Quality & Access) · MHRA

Panelist
Claire Harrison

Chief Digital and Technology Officer · Medicines and Healthcare products Regulatory Agency (MHRA)

Panelist
Alison Cave

Chief Safety Officer · Medicines and Healthcare Products Regulatory Agency (MHRA)

Chair